|
KIF3B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.07289954698331E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.36900005063023E-09 |
| Normal-vs-Stage2 |
1.556310E-04 |
| Normal-vs-Stage3 |
3.975800E-03 |
| Normal-vs-Stage4 |
3.62329999337163E-09 |
| Stage1-vs-Stage2 |
5.457400E-01 |
| Stage1-vs-Stage3 |
9.573200E-01 |
| Stage1-vs-Stage4 |
4.228100E-02 |
| Stage2-vs-Stage3 |
7.081000E-01 |
| Stage2-vs-Stage4 |
1.206640E-01 |
| Stage3-vs-Stage4 |
6.163800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.67510030688345E-10 |
| Normal-vs-AfricanAmerican |
3.31389999885801E-08 |
| Normal-vs-Asian |
1.0389000004718E-07 |
| Caucasian-vs-AfricanAmerican |
8.496000E-01 |
| Caucasian-vs-Asian |
1.455370E-01 |
| AfricanAmerican-vs-Asian |
4.306200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.21409565628983E-11 |
| Normal-vs-Female |
1.78482999999563E-05 |
| Male-vs-Female |
2.083000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.99510000023595E-07 |
| Normal-vs-Extreme_Weight |
5.48694423230245E-12 |
| Normal-vs-Obese |
1.38189999998595E-06 |
| Normal-vs-Extreme_Obese |
1.194310E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.745200E-01 |
| Normal_Weight-vs-Obese |
1.667850E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.519400E-01 |
| Extreme_Weight-vs-Obese |
3.781700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.741200E-01 |
| Obese-vs-Extreme_Obese |
8.461600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.43919999995301E-06 |
| Normal-vs-Age(41-60Yrs) |
5.50690000045151E-07 |
| Normal-vs-Age(61-80Yrs) |
9.18349840617338E-11 |
| Normal-vs-Age(81-100Yrs) |
4.08910016957975E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.192600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.723200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.252100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.115170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.204420E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.514250E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.51989998364854E-09 |
| Normal-VS-Type2 PRCC |
2.33219998868606E-09 |
| Normal-VS-KIRP CIMP |
8.81069994740358E-09 |
| Normal-VS-Unclassified PRCC |
8.558000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.558230E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.589900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.562190E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.037600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.336400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.722200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.13449999897364E-08 |
| Normal-vs-N1 |
1.71679999999563E-05 |
| Normal-vs-N2 |
5.2994999999445E-07 |
| N0-vs-N1 |
7.263000E-01 |
| N0-vs-N2 |
3.474200E-01 |
| N1-vs-N2 |
1.817770E-01 |
|
|
